Ella Solomon, PA
Medical · Aubrey, TXNPI 1437692480
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (43.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Sun Pharmaceutical Industries Inc. at 48.9% of the total. Reporting peaked in 2021 at $12,720 and has fallen 82.7% since, to $2,199 in 2024. Among medical clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $59.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$12K
- E.r. Squibb & Sons, L.L.C.$3K
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Johnson & Johnson$1K
- Boehringer Ingelheim$1K
- plus $4K from 19 others
What the payments were for
- Consulting fees$3,67515%
- Speaking & faculty fees$10,54543%
- Travel & lodging$320%
- Food & beverage$9,39239%
- Education$6993%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 52 | $11,893 |
| E.r. Squibb & Sons, L.L.C. | 32 | $3,224 |
| AbbVie | 56 | $1,948 |
| Regeneron Healthcare Solutions, Inc. | 51 | $1,336 |
| Johnson & Johnson | 75 | $1,329 |
| Boehringer Ingelheim | 6 | $1,024 |
| Almirall LLC | 16 | $594 |
| Lilly USA, LLC | 26 | $447 |
| Sanofi | 22 | $432 |
| Incyte Corporation | 9 | $411 |
| LEO Pharma Inc. | 11 | $308 |
| Journey Medical Corporation | 2 | $250 |
| Dermavant Sciences, Inc. | 2 | $221 |
| Novartis | 3 | $168 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 10 | $160 |
| Pfizer | 7 | $129 |
| Biofrontera Inc. | 7 | $80 |
| Mayne Pharma Commercial LLC | 8 | $74 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Amgen | 3 | $67 |
| Galderma Laboratories, L.p. | 4 | $51 |
| Dermira, Inc. | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Nabriva Therapeutics, PLC | 2 | $29 |
| Genentech USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,343 in reported general payments places this provider in the 95th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $111,869 |
| Clobetasol Propionate | 21 | $844 |
| Ketoconazole | 18 | $278 |
| Triamcinolone Acetonide | 13 | $127 |
| Mupirocin | 14 | $100 |
Paid to pharmacies, not to this prescriber.
Other medical in Aubrey
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
- Janine ShinnDallas$84K
- Radha BernanderKaty$74K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.